Review Topical Sections

Modulation of antimicrobial efflux pumps of the major facilitator superfamily in Staphylococcus aureus

  • Variants of the microorganism Staphylococcus aureus which are resistant to antimicrobial agents exist as causative agents of serious infectious disease and constitute a considerable public health concern. One of the main antimicrobial resistance mechanisms harbored by S. aureus pathogens is exemplified by integral membrane transport systems that actively remove antimicrobial agents from bacteria where the cytoplasmic drug targets reside, thus allowing the bacteria to survive and grow. An important class of solute transporter proteins, called the major facilitator superfamily, includes related and homologous passive and secondary active transport systems, many of which are antimicrobial efflux pumps. Transporters of the major facilitator superfamily, which confer antimicrobial efflux and bacterial resistance in S. aureus, are good targets for development of resistance-modifying agents, such as efflux pump inhibition. Such modulatory action upon these antimicrobial efflux systems of the major facilitator superfamily in S. aureus may circumvent resistance and restore the clinical efficacy of therapy towards S. aureus infection.

    Citation: Manjusha Lekshmi, Parvathi Ammini, Jones Adjei, Leslie M. Sanford, Ugina Shrestha, Sanath Kumar, Manuel F. Varela. Modulation of antimicrobial efflux pumps of the major facilitator superfamily in Staphylococcus aureus[J]. AIMS Microbiology, 2018, 4(1): 1-18. doi: 10.3934/microbiol.2018.1.1

    Related Papers:

    [1] Xiaowen Jia, Jingxia Chen, Kexin Liu, Qian Wang, Jialing He . Multimodal depression detection based on an attention graph convolution and transformer. Mathematical Biosciences and Engineering, 2025, 22(3): 652-676. doi: 10.3934/mbe.2025024
    [2] Shengfu Lu, Xin Shi, Mi Li, Jinan Jiao, Lei Feng, Gang Wang . Semi-supervised random forest regression model based on co-training and grouping with information entropy for evaluation of depression symptoms severity. Mathematical Biosciences and Engineering, 2021, 18(4): 4586-4602. doi: 10.3934/mbe.2021233
    [3] R. Loula, L. H. A. Monteiro . On the criteria for diagnosing depression in bereaved individuals: a self-organizing map approach. Mathematical Biosciences and Engineering, 2022, 19(6): 5380-5392. doi: 10.3934/mbe.2022252
    [4] Yanling An, Shaohai Hu, Shuaiqi Liu, Bing Li . BiTCAN: An emotion recognition network based on saliency in brain cognition. Mathematical Biosciences and Engineering, 2023, 20(12): 21537-21562. doi: 10.3934/mbe.2023953
    [5] Jiacan Xu, Donglin Li, Peng Zhou, Chunsheng Li, Zinan Wang, Shenghao Tong . A multi-band centroid contrastive reconstruction fusion network for motor imagery electroencephalogram signal decoding. Mathematical Biosciences and Engineering, 2023, 20(12): 20624-20647. doi: 10.3934/mbe.2023912
    [6] Xian Hua, Jing Li, Ting Wang, Junhong Wang, Shaojun Pi, Hangcheng Li, Xugang Xi . Evaluation of movement functional rehabilitation after stroke: A study via graph theory and corticomuscular coupling as potential biomarker. Mathematical Biosciences and Engineering, 2023, 20(6): 10530-10551. doi: 10.3934/mbe.2023465
    [7] R. Loula, L. H. A. Monteiro . Monoamine neurotransmitters and mood swings: a dynamical systems approach. Mathematical Biosciences and Engineering, 2022, 19(4): 4075-4083. doi: 10.3934/mbe.2022187
    [8] Enas Abdulhay, Maha Alafeef, Hikmat Hadoush, V. Venkataraman, N. Arunkumar . EMD-based analysis of complexity with dissociated EEG amplitude and frequency information: a data-driven robust tool -for Autism diagnosis- compared to multi-scale entropy approach. Mathematical Biosciences and Engineering, 2022, 19(5): 5031-5054. doi: 10.3934/mbe.2022235
    [9] Su-na Zhao, Yingxue Cui, Yan He, Zhendong He, Zhihua Diao, Fang Peng, Chao Cheng . Teleoperation control of a wheeled mobile robot based on Brain-machine Interface. Mathematical Biosciences and Engineering, 2023, 20(2): 3638-3660. doi: 10.3934/mbe.2023170
    [10] Yujie Kang, Wenjie Li, Jidong Lv, Ling Zou, Haifeng Shi, Wenjia Liu . Exploring brain dysfunction in IBD: A study of EEG-fMRI source imaging based on empirical mode diagram decomposition. Mathematical Biosciences and Engineering, 2025, 22(4): 962-987. doi: 10.3934/mbe.2025035
  • Variants of the microorganism Staphylococcus aureus which are resistant to antimicrobial agents exist as causative agents of serious infectious disease and constitute a considerable public health concern. One of the main antimicrobial resistance mechanisms harbored by S. aureus pathogens is exemplified by integral membrane transport systems that actively remove antimicrobial agents from bacteria where the cytoplasmic drug targets reside, thus allowing the bacteria to survive and grow. An important class of solute transporter proteins, called the major facilitator superfamily, includes related and homologous passive and secondary active transport systems, many of which are antimicrobial efflux pumps. Transporters of the major facilitator superfamily, which confer antimicrobial efflux and bacterial resistance in S. aureus, are good targets for development of resistance-modifying agents, such as efflux pump inhibition. Such modulatory action upon these antimicrobial efflux systems of the major facilitator superfamily in S. aureus may circumvent resistance and restore the clinical efficacy of therapy towards S. aureus infection.


    Depression is a serious mental health problem that can be very harmful to individuals and society. Depression can seriously affect the emotional and psychological state of patients, causing them to feel sad, hopeless, and disinterested for long periods of time. This persistent low mood can cause a person to lose enthusiasm and motivation for life, affecting work, school and relationships. The World Health Organization (WHO) [1] highlights that depression is one of the most common mental illnesses in the world, with approximately 340 million people worldwide suffering from depression. This means that about one in 20 people are affected by depression. Early and accurate diagnosis and timely and effective treatment are essential to minimizing the harm caused by depression.

    The treatment of depression continues to pose challenges despite years of development. Antidepressant drugs exert their therapeutic effects by modulating the interaction of neurotransmitter systems across multiple brain regions. Different types of antidepressants use different principles and mechanisms to treat depression. Healthy subjects receiving venlafaxine showed a decrease in theta-band rhythms in the midline-and-right-frontal (MRF) region at 48 hours and at 1 week after randomization [2]. Selective serotonin reuptake inhibitors may restore abnormal brain activity in the inferior frontal cortex of patients [3]. However, successive empirical attempts to identify initial resistance to antidepressant treatment can complicate clinical drug therapy progressively [4]. Thus, the exact medication regimen to be used needs to be carefully considered.

    Like medication, transcranial magnetic stimulation (TMS) is a commonly used clinical treatment for depression. TMS is a non-invasive technique that utilizes a magnetic field to induce electrical currents that stimulate specific areas of the brain under an applied coil. Noda et al. used TMS to repetitively stimulate the right prefrontal cortex of depressed patients. This resulted in rapid modulation of EEG activity in depressed patients [5]. Hutton et al. found that stimulation of the left dorsolateral prefrontal lobe of the brain using high-frequency TMS was effective in alleviating depressive symptoms [6]. They concluded that different TMS stimulation programs have different therapeutic effects on depressed patients. Therefore, studying the functional abnormalities of brain regions in patients with depression is crucial for the development and improvement of clinical treatment programs. Neuroimaging techniques are widely used in depression research. Electroencephalography and functional magnetic resonance imaging (fMRI) techniques have been shown to be effective and reliable in studying functional brain abnormalities in patients.

    Functional connectivity is the statistical correlation between different regions within the brain, which reflects the functional collaboration and communication between brain regions. Changes in functional connectivity may indicate the neurobiological basis of disease and can serve as a biomarker for diagnosis and assessment of therapeutic efficacy. Naho et al. [7] found that antidepressants had a heterogeneous effect on the identified FCs of 25 melancholic MDDs. They suggested that regions with abnormal functional connectivity such as the left dorsolateral prefrontal cortex, inferior frontal gyrus, and others could be targets for future optimization of depression treatment regimens. Hui et al. [8] found that mindfulness-based cognitive therapy strengthened functional connections between the amygdala and middle frontal gyrus, and this increase in communication correlated with improvements in clinical symptoms.

    Effective connectivity is one of the common EEG indicators of functional networks. It describes the causal relationships between different brain regions and the way information is transmitted and interacts in the brain [9]. By inferring the directionality and strength of information transfer, researchers can construct a more accurate brain connectivity map that reveals the functional connectivity patterns between different brain regions. For instance, Alena et al. utilized partial directed coherence (PDC) to evaluate the overall efficiency of the entire brain and graph-theoretic metrics of specific structures, identifying the significant role of the amygdala in depression [10]. In another study, Olejarczyk et al. employed direct transfer function (DTF) to assess the therapeutic effects of transcranial magnetic stimulation and determine the most suitable stimulation protocol [11].

    However, the prediction models based on PDC and DTF have certain limitations and lack flexibility in capturing the frequency domain characteristics of nonlinear systems. These models are applicable to lengthy low-latitude data series. Otherwise, the problem of data interference and dimension explosion will occur. Thus, it is difficult to handle multivariate systems like EEG signals.

    PTE is an information-theoretic method that provides insights into the direction of information transfer, indicating which variable exerts a greater influence on another variable [12]. This is crucial for understanding causality and information flow within complex systems. Unlike other methods, PTE can detect nonlinear causality and information transfer without relying on a specific model of the input data. It is particularly well-suited for estimating directional connectivity in brain networks based on phase information. In the context of resting-state functional networks, the directional changes in preferred information flow between sources can be effectively studied using directional phase transfer entropy (dPTE) [13]. As a result, PTE offers significant advantages in analyzing information flow within brain networks and resting-state functional networks. It not only indicates the strength of connectivity between brain regions in the same way as conventional functional connectivity metrics, but also indicates the directionality of that connectivity in the same way as the PDC predictive model.

    We used standard low-resolution electromagnetic tomography (sLORETA) [14] to calculate current density distributions in various regions of the brain. In this way, an adaptive spatial model of the scalp source was constructed. EEG signals based on lead orientation can be converted to anatomically based time series so that the time series correspond to the scalp spatial model signal sources. Compared to the lead position method, the signal source localization method is more suitable for brain partitioning. This makes the processed data more interpretable.

    We also calculated the partial transfer entropy (PTE) index between each pair of time series and considered not only the strength of functional connectivity, but also the ability to determine the specific direction of information flow. dPTE requires no input model data and is well suited to estimating the connectivity of large-scale human brain networks. Statistical analyses of dPTE feature matrices of different dimensions were performed for depressed and healthy individuals. We analyzed depression EEG in different frequency bands, lobes, brain regions with abnormal connectivity and characteristics of information flow between brain regions. These findings can provide excellent support and a reliable basis for the implementation of clinical treatment protocols for depression.

    The organization of the paper is as follows: In the second section, we describe our research methodology and experimental design as well as demographic data statistics of the subjects. In the third section, we present the results of the experiment, including the statistical analysis of the data and the analysis of the indicators. In the fourth section, we provide an in-depth discussion of these results, explore their additions to the literature and their implications at the theoretical and applied levels, summarize our major findings, and propose directions for future research.

    We recruited 22 depressed adolescents and 22 healthy adolescents, and the difference in age between the two groups was not statistically significant (p > 0.05). The subjects were right-handed, with normal or corrected vision, no history of mental illness, drug addiction, or alcoholism, and were all tested and diagnosed by a professional doctor using the Hamilton Depression Scale in a hospital in Changzhou City. Normal subjects had HAMD scores around 3, while depressed subjects had scores as high as around 20.

    Before the experiment, all were informed of the details of the experiment and signed an informed consent form with the subjects and their guardians to participate in this experiment voluntarily. EEG signals were collected from subjects in the resting state with eyes open for 5 minutes and eyes closed for 5 minutes. The experimental environment was quiet, had a comfortable temperature, there was no noise and visual interference, and the subjects were asked to sit still and stay awake, avoiding large movements as much as possible.

    Table 1.  Demographic and clinical data for patients with depression and controls groups.
    Variables Healthy group Depressed patients P-value
    Sex ratio, male/female 11/11 12/10 NA
    Age (years) 16.25±1.4 16.17±0.96 0.91
    Education(years) 9.2±1.52 9±1.71 0.54
    Observer-rated depression scale (HAMD-17) 3.2±1.64 20.3±4.7 < 0.001
    Handedness (left/right) 0/22 0/22 NA
    The Mann-Whitney U test was used for age, age at education, and HAME scale scores.

     | Show Table
    DownLoad: CSV

    EEG data acquisition was performed using a 64-lead EEG acquisition system from EGI with Net Station software, with the electrode position distribution based on the 10-10 international standard, the reference electrode being the Cz electrode, the sampling frequency being 500 Hz, and the upper limit of the electrode impedance being set to 50 kΩ.

    The raw data collected were processed to make it compatible with MATLAB software by converting it into a raw format using Net Station software. Subsequently, the data underwent preprocessing using the EEGLAB toolbox (version 2022), following these specific steps: band-pass filtering from 0.5 Hz to 45 Hz, reconversion of the reference point to an average reference, removal of artifacts such as blinks and head movements using independent component analysis (ICA), and replacement of bad leads with signal drift by averaging the data overlay with neighboring leads. Finally, a 3-minute clean data segment was selected for further analysis.

    We employed a rigorous approach to map cortical current source density (CSD) utilizing a distributed model comprising 15,000 current dipoles. The spatial distribution and orientations of these dipoles were determined based on cortical regions defined in the brain neurological institute (MNI) standard brain model [15]. To ensure compatibility with the sensor network's geometry, the MNI model was suitably adapted. The cortical model for EEG analysis was generated using the openMEEG boundary element method [16], which calculated a source space model of the cortical surface in a block-by-block fashion. In order to mitigate the impact of slow bias in the data, the noise covariance was diligently computed.

    The standard MNLS solution is given by the following equation:

    $ j=argminmLj+λj∥=TmwithT=LT[LLT+λ1]
    $
    (1)

    where j is the unknown current density vector, m is the measured data vector, L is the leading field matrix, † denotes the Moore-Penrose pseudo-inverse matrix, and 1 is the unit matrix.

    In the Bayesian view, the potential variance $ {\mathrm{S}}_{\mathrm{m}} $ is a function of the noise variance $ {\mathrm{S}}_{\mathrm{m}, \mathrm{n}\mathrm{o}\mathrm{i}\mathrm{s}\mathrm{e}} = \mathrm{\lambda }1 $ and the prior source variance $ {\mathrm{S}}_{\mathrm{j}, \mathrm{p}\mathrm{r}\mathrm{i}\mathrm{o}\mathrm{r}} = 1 $:

    $ Sm=LSj,priorLT+Sm,noise=LLT+λ1
    $
    (2)

    The variance $ {\mathrm{S}}_{\mathrm{j}} $ of the estimated current density j is given by the following equation:

    $ Sj=TSmTT=LT[LSj,priorLT+λ1]
    $
    (3)

    The sLORETA metric of the source location k is computed as based on its corresponding 3-dimensional subvector jk and the 3 × 3 block diagonal elements $ {\mathrm{S}}_{\mathrm{j}, \mathrm{k}} $ of the covariance matrix $ {\mathrm{S}}_{\mathrm{j}} $ :

    $ {{\mathrm{j}}_{\mathrm{k}}}^{\mathrm{T}}{\left[{\mathrm{S}}_{\mathrm{j}, \mathrm{k}}\right]}^{-1}{\mathrm{j}}_{\mathrm{k}} $ (4)

    sLORETA can be written as a linear operator applied to the data vector m:

    $ {\left[{\mathrm{S}}_{\mathrm{j}, \mathrm{k}}\right]}^{-0.5}{\mathrm{j}}_{\mathrm{k}} = {\left[{\mathrm{S}}_{\mathrm{j}, \mathrm{k}}\right]}^{-0.5}{\mathrm{T}}_{\mathrm{k}}{\rm{m}} $ (5)

    where Tk denotes the row in T associated with k. The activation of 15,000 dipoles was computed from the EEG time series using a weighted minimum-paradigm estimator.

    Finally, according to the Desikan-Killiany (DK) Brain Atlas [17], dipoles were categorized into 68 regions of interest (ROIs). The activity of each ROI was generated by averaging the CSDs of all voxels within that region. The 68 ROIs were further categorized into 14 regions based on their anatomical location on the cortex: LPF, RPF, LF, RF, LC, RC, LP, RP, LO, RO, LT, RT, LL, and RL.

    PTE is a transfer entropy of signal phase time series based on the transfer entropy (TE) principle, which is suitable to study information transfer in high-lead EEG signals.

    TE is a metric that measures the transfer of information between stochastic processes. It is based on the comparison of conditional and joint probabilities and is used to describe the degree of causal influence of one random variable on another. Transfer entropy measures the flow of information from one random variable X to another random variable Y. The formula for transfer entropy is:

    $ TE\left(X\to Y\right) = H\left(Y|{Y}^{\mathrm{\text{'}}}\right)-H\left(Y|{Y}^{\mathrm{\text{'}}}, {X}^{\mathrm{\text{'}}}\right) $ (6)

    where H(Y|Y') is the conditional entropy of the Y value at the current moment given the Y value Y' at the past moment; H(Y|Y', X') is the conditional entropy of the Y value at the current moment given the Y value Y' and X value X' at the past moment. A positive transfer entropy indicates that X has a causal effect on Y, and a zero or negative entropy indicates that X has no causal effect on Y.

    PTE estimates the strength of the causal relationship between two signals based on the instantaneous phase difference computed using the Hilbert transform and controls for possible causal effects of other signals. It is often used to assess causal relationships between a wider range of variables:

    $ PTE\left(X\to Y\right) = I\left({\theta }_{y}\left(t\right), {\theta }_{x}\left({t}^{\mathrm{\text{'}}}\right)|{\theta }_{y}\left({t}^{\mathrm{\text{'}}}\right)\right) $ (7)

    where θx(t′) and θy(t′) are the past states of the instantaneous phase time series of X(t) and Y(t) at t′ = t - δt, respectively. There is no specific upper limit on the PTE; thus, we normalize the PTE using the dPTE:

    $ {\mathrm{d}\mathrm{P}\mathrm{T}\mathrm{E}}_{x\to y} = {PTE}_{x\to y}/\left({PTE}_{x\to y}+{PTE}_{y\to x}\right) $ (8)

    The value of dPTExy ranges from 0 to 1. For dPTExy > 0.5, the signal flows preferentially from X to Y, and for dPTExy < 0.5, the signal flows from Y to X. Subtracting 0.5 for all dPTExy, the information flow direction is defined in terms of positive and negative.

    We apply dPTE to high-lead EEG and using dPTE in the 0.5-48 Hz frequency range to estimate the directional FC between all combinations of the corresponding source time series and extracting significant network connections using alignment tests. In order to ascertain the clear directionality of information flow between two regions of interest (ROIs), a nonparametric alignment test was employed. To validate the strength of the information flow, 5,000 random permutations were conducted for each dPTE value. This procedure determined whether the observed information flow was significantly different from zero. The null distribution was symmetrically generated around the mean of the null hypothesis. Subsequently, p-values were obtained for each state of consciousness, and these p-values were adjusted for multiple comparisons using the tmax method to effectively control for family-wise error rates.

    In this study, a second-order Butterworth bandpass filter was used to divide the signal into four frequency bands: delta (0.5-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), and beta (13-30 Hz). For each band, we split the backtracked time series into smaller windows (5 seconds long) to generate the dPTE matrix and average it.

    To assess the differences between groups, Friedman's test was employed to determine the number of information flows exhibiting significant disparities across various brain regions. Regions of interest (ROIs) displaying significant differences between groups were further analyzed, and their corresponding directed Partial Transfer Entropy (dPTE) values were extracted as feature datasets for classification validation. To investigate the discriminative capacity of the depression detection indices under investigation, a SVM classifier was selected for 5-fold cross-validation. The performance of the classifier was evaluated based on criteria such as specificity, sensitivity, and accuracy.

    Figure 1.  Flow chart of depression brain information flow analysis technique.

    The PTE data were subjected to normalization, resulting in a dPTE matrix with values ranging from 0 to 1. Since the distribution of dPTE values did not conform to a normal distribution, we use the nonparametric permutation test to confirm that the information flow between two ROIs has a clear directionality. The permutation test involved creating a dataset comprising information flow intensities from all subjects, followed by 5,000 random permutations to assess whether the information flow intensities significantly deviated from zero. The null distribution was symmetrically centered around the mean of the null hypothesis. A p-value was obtained for each state of consciousness, and multiple corrections using the "tmax" method were applied to control for family-wise error rates.

    Figure 2.  Significant directional connectivity matrices in four frequency bands for depressed patients and controls. The color blocks in the xth row and yth column of each connection matrix indicate the dPTE values of the xth ROI flowing to the yth ROI: dPTExy.

    The dPTExy value is between 0 and 1. When 0.5 < dPTExy < 1, it means that the information flow is prioritized from x to y; When 0 < dPTExy < 0.5, it means that the information flow is from y to x; When dPTExy, = 0 it indicates that the information flow between signal x and signal y is in equilibrium.

    Among them, delta and theta frequency bands had less significant information flow, and alpha and beta significant information flow was more. Moreover, in all frequency bands, the intensity of information flow was higher in the healthy group of subjects than in the depressed group.

    The 68 time series were reordered according to brain partitioning and a Friedman test was performed between groups. As shown in Figure 3, the between-group differences between the depressed and subject groups were concentrated in the theta and alpha bands, and the regions presenting differences were relatively concentrated. For this reason, the amount of information flow from each region to the other regions was counted. Brain regions were divided into LPF, RPF, LF, RF, LC, RC, LP, RP, LO, RO, LT, RT, LL, and RL according to the DK partitioning. The number of information streams generated by ROIs within each region was averaged after summation, and the results are shown in Figure 4.

    Figure 3.  Results of Friedman's test between groups.
    Figure 4.  Number of information flows in brain regions.

    Significant differences in brain connectivity were observed between the depressed and healthy groups. Specifically, these differences were found to be more prominent in the right hemisphere regions compared to the left hemisphere regions. The occipital regions exhibited greater disparities in connectivity compared to other brain regions. Notably, the differences in connectivity within the right central hook region were particularly pronounced in the alpha frequency band.

    There was a significant increase in information flow between the two halves of the brain in depressed subjects, but there is a lack of information flow between more distant brain regions. The brain regions corresponding to the DK template are shown in Table 2. Using the values of information flow with significant differences between alpha and theta in Figure 5 as a dataset, the model performance achieves 91% correctness using an SVM classifier with a five-fold cross-validation.

    Table 2.  Brain regions showing significant differences in information flow.
    Delta Theta Alpha Beta
    LO 0.037*
    cuneus
    RPF 0.009**
    frontal pole
    RT 0.025*
    entorhinal
    LT 0.046*
    superior temporal
    RP 0.041*
    supramarginal
    LP 0.029*
    supramarginal
    RF 0.005**
    Pars triangularis
    RL 0.036*
    rostral anterior cingulate
    RC 0.007**
    paracentral
    RT 0.004**
    parahippocampal
    RO 0.004**
    Lateral occipital
    LF 0.028*
    superior frontal
    RT 0.045*
    middle temporal
    RPF 0.014*
    pars orbitalis
    LO 0.038**
    lateral occipital
    LF 0.14*
    caudal middle frontal
    RT 0.17*
    entorhinal
    T 0.43*
    middle temporal
    LT 0.004**
    parahippocampal
    RO 0.007**
    pericalcarine
    RC 0.002**
    precentral
    RP 0.006**
    inferior parietal
    RT 0.029*
    temporal pole

     | Show Table
    DownLoad: CSV
    Figure 5.  Information flow loops. The solid lines indicate significant directed information flow between the two ROIs (permutation test, P < 0.05), blue lines indicate stronger information flow in the healthy group than in the depressed group, and green lines indicate stronger information flow in the depressed group than in the healthy group.

    To mitigate the negative effects of depression on patients and to aid in the development of a drug or TMS programs, it would be useful to study abnormalities in the areas of brain function associated with depression and abnormalities in the connections between brain regions. Researchers using functional magnetic resonance imaging have successfully identified different areas of the brain with impaired function in patients with different subtypes of depression [18]. Although fMRI provides valuable information, the equipment is expensive and not easy to use. In contrast, EEG technology is inexpensive, easy to administer, and is an important tool for clinical assessment and community screening.

    Most EEG studies rely to some extent on graph theory to categorize and identify subjects through functional connectivity matrices. Hasanzadeh et al. [12] reported that depressed individuals have stronger than normal brain functional connectivity and a more randomized brain network structure. Although these biomarkers achieved high classification accuracy, graph theoretic results are difficult to interpret physiologically. However, Orgo et al. [19] found that the inclusion of graph theory metrics did not significantly improve the accuracy of functional connectivity metrics in distinguishing between depressed and control groups. Therefore, it remains a challenge to study the effects between depressive foci and brain regions to complement clinical medication and therapeutic modalities such as transcranial magnetic stimulation.

    In this study, we investigated whether the functional connectivity between certain brain regions in the EEG signals of depressed patients is abnormal in the resting state and whether there are differences in the direction of information flow compared to the healthy group. We tracked EEG signals using sLORETA and then calculated the PTE effective connectivity matrix. By performing a permutation test on the data from all subjects, we found that the overall information flow in resting-state EEG occurs predominantly in the alpha and beta frequency bands. Notably, the healthy group showed a higher intensity of overall information flow compared to the depressed group. This observation may be due to the inverse relationship between alpha power and cortical activity. That is, a decrease in alpha power in the posterior regions of the brain may indicate an increase in neuronal excitability.

    We performed Friedman's test on the PTE matrix to compare the healthy and depressed groups and found significant differences in the alpha and beta frequency bands. Specifically, the depressed group showed increased interhemispheric connectivity and decreased teleconnection. This increased interhemispheric functional connectivity may be due to the disruption of corpus callosum integrity [20], resulting in imbalances in hemispheric functional coordination. In addition, depressed patients showed reduced grey matter volume in the left precentral gyrus and increased grey matter volume in the right thalamus [21]. These abnormal grey matter volumes and connectivity patterns reflect abnormal intrinsic wiring costs of brain structures, resulting in atypical topological properties of functional connectivity.

    Comparing the two groups of subjects, we observed greater differences in the right than in the left brain regions, especially in the right central lobe region, where the differences in the alpha band were most pronounced. theta and beta bands in the left occipital and right frontal lobes showed similar characteristics. In addition, the intensity of information flow was consistent with depression scores. Similarly, Carola et al. found increased functional connectivity in the right frontal and central regions of the brain in depressed patients [22]. A study of transcranial magnetic stimulation targeting isolated cerebral hemispheres showed the potential to alleviate cerebral hemispheric imbalances and was effective in improving core depressive factors and anxiety symptoms in patients [23].

    Other researchers looked at lesions in the occipital and right frontal lobes and found that occipital curvature was more common in depressed people than in healthy people. Occipital asymmetry and occipital curvature, although different phenomena, may be due to incomplete neural pruning, limited cranial space for brain growth, or ventricular enlargement exacerbating the natural occipital curvature pattern, resulting in brain compression and the need to 'wrap' the other occipital lobe [24]. A recent meta-analysis showed that hyperconnectivity in the prefrontal and anterior cingulate regions of the default mode network (DMN) is primarily associated with rumination, highlighting the critical role of prefrontal regions in this process [25]. In contrast, hemodynamic activation in the right dorsolateral prefrontal cortex (DLPFC) and right frontal pole cortex (FPC) was significantly increased in the anxious-depressed group compared to the non-anxious-depressed and healthy groups [26].

    There was also a significant increase in the strength of information flow from the parahippocampal gyrus and middle temporal gyrus in the temporal lobe. Researchers using functional magnetic resonance imaging found a higher prevalence of hippocampal structural abnormalities in depressed patients, accompanied by increased activity within the brain's default mode network and increased extratemporal activation compared to the non-depressed group [27]. In particular, abnormal and excessive functional connectivity was observed in the right parietal lobe across both the delta and beta frequency bands, particularly in relation to the left central hook. Hou et al. targeted the parietal lobe and observed significant rehabilitative outcomes following four weeks of neurofeedback training [28].

    In summary, extensive research has consistently shown significant inter-individual variability in the neurophysiological features associated with depressive symptoms. Rather than being limited to specific local changes, pathophysiological changes in depression appear to involve multiple brain regions [29]. We found that depression is associated with abnormalities in information flow within regions such as the occipital lobe, right frontal lobe, right temporal lobe and central sulcus. The depressed patients generally showed a decrease in long-range information flow between the ipsilateral anterior and posterior regions of the brain, and an increase in information flow between hemispheres. Notably, these connectivity differences were more pronounced in the right side of the brain compared to the left side. The data set used in this study consisted of dPTE values representing information flow and showed statistically significant differences in the alpha and theta bands, with a classification accuracy of 91%. These findings suggest that these abnormalities may contribute to depressive episodes. Given the variability between patients and the potential differences in underlying pathogenesis, future treatment protocols for depression should take these factors into account. Our approach may help clinicians to develop individualized treatment plans tailored to the specific needs of each depressed individual.

    The authors declared that they have no conflicts of interest to this work.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This work is partly supported by the project of Jiangsu Key Research and Development Plan (BE2021012-5 and BE2021012-2), Changzhou Science and Technology Bureau Plan (CE20225034), Key Laboratory of Brain Machine Collaborative Intelligence Foundation of Zhejiang Province (2020E10010-04), and Human-Machine Intelligence and Interaction International Joint Laboratory Project.

    Please contact the correspondence authors for data request.

    [1] Levy SB (1992) Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Ch 36: 695–703. doi: 10.1128/AAC.36.4.695
    [2] Higgins CF (2007) Multiple molecular mechanisms for multidrug resistance transporters. Nature 446: 749–757. doi: 10.1038/nature05630
    [3] Sadee W, Drubbisch V, Amidon GL (1995) Biology of membrane transport proteins. Pharm Res 12: 1823–1837. doi: 10.1023/A:1016211015926
    [4] West IC (1980) Energy coupling in secondary active transport. BBA-Rev Biomembranes 604: 91–126. doi: 10.1016/0005-2736(80)90586-6
    [5] Boudker O, Verdon G (2010) Structural perspectives on secondary active transporters. Trends Pharmacol Sci 31: 418–426. doi: 10.1016/j.tips.2010.06.004
    [6] Kumar S, Varela MF (2012) Biochemistry of bacterial multidrug efflux pumps. Int J Mol Sci 13: 4484–4495. doi: 10.3390/ijms13044484
    [7] Schindler BD, Kaatz GW (2016) Multidrug efflux pumps of Gram-positive bacteria. Drug Resist Update 27: 1–13. doi: 10.1016/j.drup.2016.04.003
    [8] Alnaseri H, Arsic B, Schneider JE, et al. (2015) Inducible expression of a resistance-nodulation-division-type efflux pump in Staphylococcus aureus provides resistance to linoleic and arachidonic acids. J Bacteriol 197: 1893–1905. doi: 10.1128/JB.02607-14
    [9] Chen J, Morita Y, Huda MN, et al. (2002) VmrA, a member of a novel class of Na+-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J Bacteriol 184: 572–576. doi: 10.1128/JB.184.2.572-576.2002
    [10] Evans K, Passador L, Srikumar R, et al. (1998) Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol 180: 5443–5447.
    [11] Martinez JL, Sanchez MB, Martinez-Solano L, et al. (2009) Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 33: 430–449. doi: 10.1111/j.1574-6976.2008.00157.x
    [12] Marger MD, Saier MH (1993) A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci 18: 13–20. doi: 10.1016/0968-0004(93)90081-W
    [13] Pao SS, Paulsen IT, Saier MH (1998) Major facilitator superfamily. Microbiol Mol Biol R 62: 1–34.
    [14] Paulsen IT, Brown MH, Skurray RA (1996) Proton-dependent multidrug efflux systems. Microbiol Rev 60: 575–608.
    [15] Van Bambeke F, Balzi E, Tulkens PM (2000) Antibiotic efflux pumps. Biochem Pharmacol 60: 457–470. doi: 10.1016/S0006-2952(00)00291-4
    [16] Ranaweera I, Shrestha U, Ranjana KC, et al. (2015) Structural comparison of bacterial multidrug efflux pumps of the major facilitator superfamily. Trends Cell Mol Biol 10: 131–140.
    [17] Murakami S, Yamaguchi A (2003) Multidrug-exporting secondary transporters. Curr Opin Struc Biol 13: 443–452. doi: 10.1016/S0959-440X(03)00109-X
    [18] Andersen JL, He GX, Kakarla P, et al. (2015) Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Env Res Pub He 12: 1487–1547. doi: 10.3390/ijerph120201487
    [19] Saier MH, Paulsen IT (2001) Phylogeny of multidrug transporters. Semin Cell Dev Biol 12: 205–213. doi: 10.1006/scdb.2000.0246
    [20] Putman M, van Veen HW, Konings WN (2000) Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol R 64: 672–693. doi: 10.1128/MMBR.64.4.672-693.2000
    [21] Bay DC, Rommens KL, Turner RJ (2008) Small multidrug resistance proteins: a multidrug transporter family that continues to grow. BBA-Biomembranes 1778: 1814–1838.
    [22] Costa SS, Viveiros M, Amaral L, et al. (2013) Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol J 7: 59–71. doi: 10.2174/1874285801307010059
    [23] Jang S (2016) Multidrug efflux pumps in Staphylococcus aureus and their clinical implications. J Microbiol 54: 1–8. doi: 10.1007/s12275-016-5159-z
    [24] McAleese F, Petersen P, Ruzin A, et al. (2005) A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Ch 49: 1865–1871. doi: 10.1128/AAC.49.5.1865-1871.2005
    [25] Koronakis V, Sharff A, Koronakis E, et al. (2000) Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405: 914–919. doi: 10.1038/35016007
    [26] Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19: 382–402. doi: 10.1128/CMR.19.2.382-402.2006
    [27] Alvarez-Ortega C, Olivares J, Martinez JL (2013) RND multidrug efflux pumps: what are they good for? Front Microbiol 4: 7.
    [28] Murakami S, Nakashima R, Yamashita E, et al. (2002) Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419: 587–593. doi: 10.1038/nature01050
    [29] Nakashima R, Sakurai K, Yamasaki S, et al. (2011) Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 480: 565–569. doi: 10.1038/nature10641
    [30] Kuroda M, Ohta T, Uchiyama I, et al. (2001) Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357: 1225–1240. doi: 10.1016/S0140-6736(00)04403-2
    [31] Smith KP, Kumar S, Varela MF (2009) Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395. Arch Microbiol 191: 903–911. doi: 10.1007/s00203-009-0521-8
    [32] Floyd JL, Smith KP, Kumar SH, et al. (2010) LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agents Ch 54: 5406–5412. doi: 10.1128/AAC.00580-10
    [33] Ubukata K, Itoh-Yamashita N, Konno M (1989) Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Ch 33: 1535–1539. doi: 10.1128/AAC.33.9.1535
    [34] Truong-Bolduc QC, Dunman PM, Strahilevitz J, et al. (2005) MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 187: 2395–2405. doi: 10.1128/JB.187.7.2395-2405.2005
    [35] Yoshida H, Bogaki M, Nakamura S, et al. (1990) Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol 172: 6942–6949. doi: 10.1128/jb.172.12.6942-6949.1990
    [36] Kaatz GW, Seo SM, Ruble CA (1993) Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Ch 37: 1086–1094. doi: 10.1128/AAC.37.5.1086
    [37] Ng EY, Trucksis M, Hooper DC (1994) Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob Agents Ch 38: 1345–1355. doi: 10.1128/AAC.38.6.1345
    [38] Ding Y, Onodera Y, Lee JC, et al. (2008) NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J Bacteriol 190: 7123–7129. doi: 10.1128/JB.00655-08
    [39] Truong-Bolduc QC, Bolduc GR, Okumura R, et al. (2011) Implication of the NorB efflux pump in the adaptation of Staphylococcus aureus to growth at acid pH and in resistance to moxifloxacin. Antimicrob Agents Ch 55: 3214–3219. doi: 10.1128/AAC.00289-11
    [40] Truong-Bolduc QC, Strahilevitz J, Hooper DC (2006) NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob Agents Ch 50: 1104–1107. doi: 10.1128/AAC.50.3.1104-1107.2006
    [41] Paulsen IT, Brown MH, Littlejohn TG, et al. (1996) Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci USA 93: 3630–3635. doi: 10.1073/pnas.93.8.3630
    [42] Tennent JM, Lyon BR, Midgley M, et al. (1989) Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol 135: 1–10.
    [43] Rouch DA, Cram DS, Berardino DD, et al. (1990) Efflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins. Mol Microbiol 4: 2051–2062. doi: 10.1111/j.1365-2958.1990.tb00565.x
    [44] Yamada Y, Hideka K, Shiota S, et al. (2006) Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus. Biol Pharm Bull 29: 554–556. doi: 10.1248/bpb.29.554
    [45] Truong-Bolduc QC, Bolduc GR, Medeiros H, et al. (2015) Role of the Tet38 efflux pump in Staphylococcus aureus internalization and survival in epithelial cells. Infect Immun 83: 4362–4372. doi: 10.1128/IAI.00723-15
    [46] Ginn SL, Brown MH, Skurray RA (2000) The TetA(K) tetracycline/H+ antiporter from Staphylococcus aureus: mutagenesis and functional analysis of motif C. J Bacteriol 182: 1492–1498. doi: 10.1128/JB.182.6.1492-1498.2000
    [47] Krulwich TA, Jin J, Guffanti AA, et al. (2001) Functions of tetracycline efflux proteins that do not involve tetracycline. J Mol Microb Biotechnol 3: 237–246.
    [48] Schwarz S, Fessler AT, Hauschild T, et al. (2011) Plasmid-mediated resistance to protein biosynthesis inhibitors in staphylococci. Ann NY Acad Sci 1241: 82–103. doi: 10.1111/j.1749-6632.2011.06275.x
    [49] Couto I, Costa SS, Viveiros M, et al. (2008) Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. J Antimicrob Chemoth 62: 504–513. doi: 10.1093/jac/dkn217
    [50] Fluman N, Bibi E (2009) Bacterial multidrug transport through the lens of the major facilitator superfamily. BBA-Proteins Proteom 1794: 738–747. doi: 10.1016/j.bbapap.2008.11.020
    [51] Brown MH, Skurray RA (2001) Staphylococcal multidrug efflux protein QacA. J Mol Microb Biotechnol 3: 163–170.
    [52] Ho J, Branley J (2012) Prevalence of antiseptic resistance genes qacA/B and specific sequence types of methicillin-resistant Staphylococcus aureus in the era of hand hygiene. J Antimicrob Chemoth 67: 1549–1550. doi: 10.1093/jac/dks035
    [53] Truong-Bolduc QC, Villet RA, Estabrooks ZA, et al. (2014) Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin. J Infect Dis 209: 1485–1493. doi: 10.1093/infdis/jit660
    [54] Handzlik J, Matys A, Kiec-Kononowicz K (2013) Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus. Antibiotics 2: 28–45. doi: 10.3390/antibiotics2010028
    [55] Li XZ, Nikaido H (2009) Efflux-mediated drug resistance in bacteria: an update. Drugs 69: 1555–1623. doi: 10.2165/11317030-000000000-00000
    [56] Huang J, O'Toole PW, Shen W, et al. (2004) Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob Agents Ch 48: 909–917. doi: 10.1128/AAC.48.3.909-917.2004
    [57] Yamada Y, Shiota S, Mizushima T, et al. (2006) Functional gene cloning and characterization of MdeA, a multidrug efflux pump from Staphylococcus aureus. Biol Pharm Bull 29: 801–804. doi: 10.1248/bpb.29.801
    [58] Grkovic S, Brown MH, Roberts NJ, et al. (1998) QacR is a repressor protein that regulates expression of the Staphylococcus aureus multidrug efflux pump QacA. J Biol Chem 273: 18665–18673. doi: 10.1074/jbc.273.29.18665
    [59] DeMarco CE, Cushing LA, Frempong-Manso E, et al. (2007) Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Ch 51: 3235–3239. doi: 10.1128/AAC.00430-07
    [60] Heytler PG (1963) Uncoupling of oxidative phosphorylation by carbonyl cyanide phenylhydrazones. I. Some characteristics of m-Cl-CCP action on mitochondria and chloroplasts. Biochemistry 2: 357–361.
    [61] Jones I, Midgley M (1985) Expression of a plasmid borne ethidium resistance determinant from Staphylococcus in Escherichia coli: evidence for an efflux system. FEMS Microbiol Lett 28: 355–358. doi: 10.1111/j.1574-6968.1985.tb00820.x
    [62] Mitchell BA, Paulsen IT, Brown MH, et al. (1999) Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J Biol Chem 274: 3541–3548.
    [63] Littlejohn TG, Paulsen IT, Gillespie MT, et al. (1992) Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol Lett 74: 259–265.
    [64] Mo XN, Li JG, Tang YC, et al. (2007) The action of active efflux system on multi-drug resistance in methicillin resistant Staphylococcus aureus. Zhonghua Jie He He Hu Xi Za Zhi 30: 40–43.
    [65] Rothstein DM, McGlynn M, Bernan V, et al. (1993) Detection of tetracyclines and efflux pump inhibitors. Antimicrob Agents Ch 37: 1624–1629. doi: 10.1128/AAC.37.8.1624
    [66] Nelson ML, Levy SB (1999) Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob Agents Ch 43: 1719–1724.
    [67] Roccaro AS, Blanco AR, Giuliano F, et al. (2004) Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Ch 48: 1968–1973. doi: 10.1128/AAC.48.6.1968-1973.2004
    [68] de Araujo RSA, Barbosa-Filho JM, Scotti MT, et al. (2016) Modulation of drug resistance in Staphylococcus aureus with coumarin derivatives. Scientifica 2016: 1–6.
    [69] Tintino SR, Morais-Tintino CD, Campina FF, et al. (2016) Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps. EXCLI J 15: 315–322.
    [70] Monte J, Abreu AC, Borges A, et al. (2014) Antimicrobial activity of selected phytochemicals against Escherichia coli and Staphylococcus aureus and their biofilms. Pathogens 3: 473–498. doi: 10.3390/pathogens3020473
    [71] Limaverde PW, Campina FF, da Cunha FA, et al. (2017) Inhibition of the TetK efflux-pump by the essential oil of Chenopodium ambrosioides L. and alpha-terpinene against Staphylococcus aureus IS-58. Food Chem Toxicol 109: 957–961.
    [72] Chovanova R, Mezovska J, Vaverkova S, et al. (2015) The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three Salvia species. Lett Appl Microbiol 61: 58–62. doi: 10.1111/lam.12424
    [73] Varela MF, Andersen JL, Ranjana KC, et al. (2017) Bacterial resistance mechanisms and inhibitors of multidrug efflux pumps belonging to the major facilitator superfamily of solute transport systems, In: Atta-ur-Rahman, Choudhary MI, Editors, Frontiers in Anti-Infective Drug Discovery, Bentham Science Publishers, 109–131.
    [74] Kumar S, He G, Kakarla P, et al. (2016) Bacterial multidrug efflux pumps of the major facilitator superfamily as targets for modulation. Infect Disord Drug Targets 16: 28–43. doi: 10.2174/1871526516666160407113848
    [75] Kumar S, Mukherjee MM, Varela MF (2013) Modulation of bacterial multidrug resistance efflux pumps of the major facilitator superfamily. Int J Bacteriol 2013: 1–15.
    [76] Pervaiz A, Khan R, Anwar F, et al. (2016) Alkaloids: An emerging antibacterial modality against methicillin resistant Staphylococcus aureus. Curr Pharm Design 22: 4420–4429. doi: 10.2174/1381612822999160629115627
    [77] Wang Y, Venter H, Ma S (2016) Efflux pump inhibitors: A novel approach to combat efflux-mediated drug resistance in bacteria. Curr Drug Targets 17: 702–719. doi: 10.2174/1389450116666151001103948
    [78] Schindler BD, Jacinto P, Kaatz GW (2013) Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics. Future Microbiol 8: 491–507. doi: 10.2217/fmb.13.16
    [79] Zhang L, Ma S (2010) Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump. Chem Med Chem 5: 811–822. doi: 10.1002/cmdc.201000006
    [80] Lemieux MJ, Song J, Kim MJ, et al. (2003) Three-dimensional crystallization of the Escherichia coli glycerol-3-phosphate transporter: a member of the major facilitator superfamily. Protein Sci 12: 2748–2756. doi: 10.1110/ps.03276603
    [81] Bhaskar BV, Babu TM, Reddy NV, et al. (2016) Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus. Drug Des Dev Ther 10: 3237–3252. doi: 10.2147/DDDT.S113556
    [82] Kumar S, Ranjana KC, Sanford LM, et al. (2016) Structural and functional roles of two evolutionarily conserved amino acid sequence motifs within solute transporters of the major facilitator superfamily. Trends Cell Mol Biol 11: 41–53.
    [83] Kakarla P, Ranjana KC, Shrestha U, et al. (2017) Functional roles of highly conserved amino acid sequence motifs A and C in solute transporters of the major facilitator superfamily, In: Arora G, Sajid A, Kalia VC, Editors, Drug Resistance in Bacteria, Fungi, Malaria, and Cancer, Springer International Publishing, 111–140.
    [84] Varela MF, Griffith JK (1993) Nucleotide and deduced protein sequences of the class D tetracycline resistance determinant: relationship to other antimicrobial transport proteins. Antimicrob Agents Ch 37: 1253–1258. doi: 10.1128/AAC.37.6.1253
    [85] Varela MF, Sansom CE, Griffith JK (1995) Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamily. Mol Membr Biol 12: 313–319. doi: 10.3109/09687689509072433
    [86] Yaffe D, Radestock S, Shuster Y, et al. (2013) Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2. Proc Natl Acad Sci USA 110: E1332–E1341. doi: 10.1073/pnas.1220497110
    [87] Luo J, Parsons SM (2010) Conformational propensities of peptides mimicking transmembrane helix 5 and motif C in wild-type and mutant vesicular acetylcholine transporters. ACS Chem Neurosci 1: 381–390. doi: 10.1021/cn900033s
    [88] Fontaine F, Hequet A, Voisin-Chiret AS, et al. (2014) First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. J Med Chem 57: 2536–2548. doi: 10.1021/jm401808n
    [89] Fontaine F, Hequet A, Voisin-Chiret AS, et al. (2015) Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives. Eur J Med Chem 95: 185–198. doi: 10.1016/j.ejmech.2015.02.056
    [90] Bharate JB, Singh S, Wani A, et al. (2015) Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump. Org Biomol Chem 13: 5424–5431. doi: 10.1039/C5OB00246J
    [91] Singh S, Kalia NP, Joshi P, et al. (2017) Boeravinone B, A novel dual inhibitor of NorA bacterial efflux pump of Staphylococcus aureus and human P-glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria. Front Microbiol 8: 1868. doi: 10.3389/fmicb.2017.01868
    [92] Lowrence RC, Raman T, Makala HV, et al. (2016) Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model. Appl Microbiol Biot 100: 9265–9281. doi: 10.1007/s00253-016-7759-2
    [93] Coelho ML, Ferreira JHL, de Siqueira Junior JP, et al. (2016) Inhibition of the NorA multi-drug transporter by oxygenated monoterpenes. Microb Pathogenesis 99: 173–177. doi: 10.1016/j.micpath.2016.08.026
    [94] Costa LM, de Macedo EV, Oliveira FA, et al. (2016) Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins. J Appl Microbiol 121: 1312–1322. doi: 10.1111/jam.13258
    [95] Tintino SR, Oliveira-Tintino CD, Campina FF, et al. (2016) Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus. Microb Pathogenesis 97: 9–13. doi: 10.1016/j.micpath.2016.04.003
    [96] Wani NA, Singh S, Farooq S, et al. (2016) Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus. Bioorg Med Chem Lett 26: 4174–4178. doi: 10.1016/j.bmcl.2016.07.062
    [97] Felicetti T, Cannalire R, Burali MS, et al. (2017) Searching for novel inhibitors of the S. aureus NorA efflux pump: Synthesis and biological evaluation of the 3-Phenyl-1,4-benzothiazine analogues. Chem Med Chem 12: 1293–1302.
    [98] Carotti A, Ianni F, Sabatini S, et al. (2016) The "racemic approach" in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives. J Pharmaceut Biomed 129: 182–189.
    [99] Diniz-Silva HT, Magnani M, de Siqueira S, et al. (2016) Fruit flavonoids as modulators of norfloxacin resistance in Staphylococcus aureus that overexpresses norA. LWT-Food Sci Technol 85: 324–326.
    [100] Lepri S, Buonerba F, Goracci L, et al. (2016) Indole-based weapons to fight antibiotic resistance: A structure-activity relationship study. J Med Chem 59: 867–891. doi: 10.1021/acs.jmedchem.5b01219
    [101] Lopes LAA, dos Santos Rodrigues JB, Magnani M, et al. (2017) Inhibitory effects of flavonoids on biofilm formation by Staphylococcus aureus that overexpresses efflux protein genes. Microb Pathogenesis 107: 193–197. doi: 10.1016/j.micpath.2017.03.033
    [102] Salaheen S, Peng M, Joo J, et al. (2017) Eradication and sensitization of methicillin resistant Staphylococcus aureus to methicillin with bioactive extracts of Berry Pomace. Front Microbiol 8: 253.
    [103] Astolfi A, Felicetti T, Iraci N, et al. (2017) Pharmacophore-based repositioning of approved drugs as novel Staphylococcus aureus NorA efflux pump inhibitors. J Med Chem 60: 1598–1604. doi: 10.1021/acs.jmedchem.6b01439
    [104] Buonerba F, Lepri S, Goracci L, et al. (2017) Improved potency of indole-based NorA efflux pump inhibitors: From serendipity toward rational design and development. J Med Chem 60: 517–523. doi: 10.1021/acs.jmedchem.6b01281
    [105] Mirza ZM, Kumar A, Kalia NP, et al. (2011) Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus. J Med Microbiol 60: 1472–1478. doi: 10.1099/jmm.0.033167-0
    [106] Huet AA, Raygada JL, Mendiratta K, et al. (2008) Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes. Microbiology 154: 3144–3153. doi: 10.1099/mic.0.2008/021188-0
    [107] Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemoth 56: 20–51. doi: 10.1093/jac/dki171
    [108] Luna VA, Heiken M, Judge K, et al. (2002) Distribution of mef(A) in gram-positive bacteria from healthy Portuguese children. Antimicrob Agents Ch 46: 2513–2517. doi: 10.1128/AAC.46.8.2513-2517.2002
    [109] Kehrenberg C, Schwarz S (2004) fexA, a novel Staphylococcus lentus gene encoding resistance to florfenicol and chloramphenicol. Antimicrob Agents Ch 48: 615–618. doi: 10.1128/AAC.48.2.615-618.2004
    [110] Kehrenberg C, Schwarz S (2006) Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Ch 50: 1156–1163. doi: 10.1128/AAC.50.4.1156-1163.2006
    [111] Kakarla P, Floyd J, Mukherjee M, et al. (2017) Inhibition of the multidrug efflux pump LmrS from Staphylococcus aureus by cumin spice Cuminum cyminum. Arch Microbiol 199: 465–474. doi: 10.1007/s00203-016-1314-5
    [112] Truong-Bolduc QC, Wang Y, Chen C, et al. (2017) Transcriptional regulator TetR21 controls the expression of the Staphylococcus aureus LmrS Efflux pump. Antimicrob Agents Ch 61: e00649-17.
  • This article has been cited by:

    1. James C. L. Chow, Computational physics and imaging in medicine, 2025, 22, 1551-0018, 106, 10.3934/mbe.2025005
  • Reader Comments
  • © 2018 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(8813) PDF downloads(1462) Cited by(44)

Figures and Tables

Figures(1)  /  Tables(1)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog